| Literature DB >> 28300789 |
Laetitia Nivelle1, Jane Hubert2, Eric Courot3, Philippe Jeandet4, Aziz Aziz5, Jean-Marc Nuzillard6, Jean-Hugues Renault7, Christophe Clément8, Laurent Martiny9, Dominique Delmas10, Michel Tarpin11.
Abstract
In the present study, resveratrol and various oligomeric derivatives were obtained from a 14 L bioreactor culture of elicited grapevine cell suspensions (Vitis labrusca L.). The crude ethyl acetate stilbene extract obtained from the culture medium was fractionated by centrifugal partition chromatography (CPC) using a gradient elution method and the major stilbenes contained in the fractions were subsequently identified by using a 13C-NMR-based dereplication procedure and further 2D NMR analyses including HSQC, HMBC, and COSY. Beside δ-viniferin (2), leachianol F (4) and G (4'), four stilbenes (resveratrol (1), ε-viniferin (5), pallidol (3) and a newly characterized dimer (6)) were recovered as pure compounds in sufficient amounts to allow assessment of their biological activity on the cell growth of three different cell lines, including two human skin malignant melanoma cancer cell lines (HT-144 and SKMEL-28) and a healthy human dermal fibroblast HDF line. Among the dimers obtained in this study, the newly characterized resveratrol dimer (6) has never been described in nature and its biological potential was evaluated here for the first time. ε-viniferin as well as dimer (6) showed IC50 values on the three tested cell lines lower than the ones exerted by resveratrol and pallidol. However, activities of the first two compounds were significantly decreased in the presence of fetal bovine serum although that of resveratrol and pallidol was not. The differential tumor activity exerted by resveratrol on healthy and cancer lines was also discussed.Entities:
Keywords: Vitis labrusca; anticancer activity; bioreactor; fibroblasts; melanoma; phytostilbenes; resveratrol
Mesh:
Substances:
Year: 2017 PMID: 28300789 PMCID: PMC6155302 DOI: 10.3390/molecules22030474
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Growth kinetic and stilbene production (resveratrol, δ-viniferin) in the 14 L Bioflo 3000 bioreactor. Concord cells were cultured with CDR from Day 0 to Day 21 and MeJA was added at Day 11.
Figure 213C-NMR chemical shift clusters obtained by applying Hierarchical Clustering Analysis on the CPC fractions of the crude ethyl acetate extract obtained from the culture medium.
Figure 3Cell viability inhibition of two different sources of trans-resveratrol. HT-144, SKMEL-28 and HDF cells were treated with various concentrations (10–100 μM) of synthetic trans-resveratrol (S-TR) and bio-produced trans-resveratrol (B-TR) for 6, 24 and 48 h. Cell viability was determined by the MTT assay. The final volume of ethanol was 0.01% and 0.1% for 10 and 100 μM concentrations, respectively. Data are expressed as the means ± SD of 3 independent experiments. Each experiment was performed in triplicate
Figure 4Cell viability inhibition of bio-produced resveratrol oligomers. HT-144, SKMEL-28 and HDF cells were treated with various concentrations (10–100 μM) of pallidol, ε-viniferin and dimer (6), three bio-produced reveratrol oligomers, for 6, 24 and 48 h. Cell viability was determined by the MTT assay. The final volume of ethanol was 0.01% and 0.1% for 10 and 100 μM concentrations, respectively. Data are expressed as the means ± SD of 3 independent experiments. Each experiment was performed in triplicate.
Figure 5Cell viability inhibition of bio-produced stilbenes (resveratrol and the three dimers) with or without FBS. HT-144, SKMEL-28 and HDF cells were treated with various concentrations (10–100 μM) of bio-produced stilbenes for 24 h with FBS (10% FBS) or not (0% FBS). Cell viability was determined by the MTT assay. The final volume of ethanol was 0.01% and 0.1% for 10 and 100 μM concentrations, respectively. Data are expressed as the means ± SD of 3 independent experiments. Each experiment was performed in triplicate.
IC50 of bioproduced stilbenes with or without FBS in HT-144, SKMEL-28 and HDF cells at 24 h as determined by the MTT assay.
| Stilbene Bioproducts | IC50 (µM) | |||||
|---|---|---|---|---|---|---|
| HT-144 | SKMEL-28 | HDF | ||||
| with FBS | without FBS | with FBS | without FBS | with FBS | without FBS | |
| Trans-resveratrol | 93.32 ± 7.60 | > 100 | > 100 | > 100 | > 100 | > 100 |
| Pallidol | > 100 | > 100 | > 100 | > 100 | > 100 | > 100 |
| ɛ-viniferin | 82.31 ± 3.23 | 17.58 ± 0.09 | 86.62 ± 2.59 | 15.88 ± 0.44 | 91.94 ± 11.34 | 16.41 ± 1.19 |
| Dimer ( | > 100 | 24.94 ± 0.62 | > 100 | 23.01 ± 0.30 | > 100 | 22.21 ± 2.61 |
Data are expressed as IC50 values (µM) and are means ± SD of 3 independent experiments.